India Cell Culture Media Market Size & Outlook, 2023-2030
India cell culture media market, 2018-2030 (US$M)
Related Markets
India cell culture media market highlights
- The India cell culture media market generated a revenue of USD 130.8 million in 2023 and is expected to reach USD 334.6 million by 2030.
- The India market is expected to grow at a CAGR of 14.4% from 2024 to 2030.
- In terms of segment, serum-free media was the largest revenue generating product in 2023.
- Serum-free Media is the most lucrative product segment registering the fastest growth during the forecast period.
Cell culture media market data book summary
| Market revenue in 2023 | USD 130.8 million |
| Market revenue in 2030 | USD 334.6 million |
| Growth rate | 14.4% (CAGR from 2023 to 2030) |
| Largest segment | Serum-free media |
| Fastest growing segment | Serum-free Media |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Serum-free Media, Classical Media, Stem Cell Culture Media, Chemically Defined Media, Specialty Media, Other Cell Culture Media |
| Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, BD, STEMCELL Technologies, PromoCell GmbH |
Other key industry trends
- In terms of revenue, India accounted for 2.8% of the global cell culture media market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China cell culture media market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 842.0 million by 2030.
Serum-free media was the largest segment with a revenue share of 34.25% in 2023. Horizon Databook has segmented the India cell culture media market based on serum-free media, classical media, stem cell culture media, chemically defined media, specialty media, other cell culture media covering the revenue growth of each sub-segment from 2018 to 2030.
In India, the Central Drugs Standardization Control Organization is the key regulatory authority responsible for approvals of preclinical, clinical trials, manufacture, and import of biological products. In addition, biological products require additional approvals by other offices and agencies, including Institutional Biosafety Committees (IBSC), Genetic Engineering Approval Council (GEAC), State Biosafety Coordination Committees (SBCC), Recombinant DNA Advisory Committee (RDAC), District Level Committees (DLC), and the Review Committee on Genetic Manipulation (RCGM).
Furthermore, the Department of Biotechnology frames guidelines to conduct research in various areas of biosciences and promote its applications in the industry and utility among people. As per National Guidelines for Stem Cell Research 2013, all institutions conducting research on human stem cells are required to register with the National Apex Committee for Stem Cell Research and Therapy (NAC-SCRT) and constitute an Institutional Committee for Stem Cell Research (IC-SCR).
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Culture Media Market Scope
Cell Culture Media Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
India cell culture media market size, by product, 2018-2030 (US$M)
India Cell Culture Media Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
